Similar articles

• Retraction notice to "Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1" [Biomed. Pharmacother. 92 (2017) 451-458].

  Wang Q, Jiang Y, Guo R, Lv R, Liu T, Wei H, Ming H, Tian X. Wang Q, et al. Biomed Pharmacother. 2022 Feb;146:112625. doi: 10.1016/j.biopha.2022.112625. Epub 2022 Jan 12. Biomed Pharmacother. 2022. PMID: 35031233 No abstract available.
• RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.

  Wang Q, Yan Y, Zhang J, Guo P, Xing Y, Wang Y, Qin F, Zeng Q. Wang Q, et al. Biomed Pharmacother. 2018 Aug;104:28-35. doi: 10.1016/j.biopha.2018.05.013. Epub 2018 May 11. Biomed Pharmacother. 2018. Retraction in: Biomed Pharmacother. 2021 Feb;134:111070. doi: 10.1016/j.biopha.2020.111070. PMID: 29758413 Retracted.
• Retraction notice to "Physcion 8-O-β-glucopyranosideregulates cell cycle, apoptosis, and invasion in glioblastoma cells through modulating Skp2" [Biomed. Pharmacother. 95 (2017) 1129-1138].

  Li W, Li F, Zhu Y, Song D. Li W, et al. Biomed Pharmacother. 2021 Dec;144:112386. doi: 10.1016/j.biopha.2021.112386. Epub 2021 Nov 10. Biomed Pharmacother. 2021. PMID: 34772577 No abstract available.
• Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities.

  Adnan M, Rasul A, Hussain G, Shah MA, Sarfraz I, Nageen B, Riaz A, Khalid R, Asrar M, Selamoglu Z, Adem Ş, Sarker SD. Adnan M, et al. Curr Drug Targets. 2021;22(5):488-504. doi: 10.2174/1389450121999201013154542. Curr Drug Targets. 2021. PMID: 33050858 Review.
• Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma.

  Zhong JT, Zhou SH. Zhong JT, et al. Oncotarget. 2017 Feb 21;8(8):14133-14146. doi: 10.18632/oncotarget.13044. Oncotarget. 2017. PMID: 27823965 Free PMC article. Review.